Covaxin may see higher uptake post authorization
3 years, 9 months ago

Covaxin may see higher uptake post authorization

Live Mint  

Uptake of the domestically developed covid-19 vaccine Covaxin may significantly increase as states that have been cautious about administering it become more confident after a full regulatory emergency licensure is given to it. Bharat Biotech International Ltd, the manufacturer of Covaxin, has submitted its interim data on the vaccine, which showed 81% efficacy, to the Drugs Controller General of India V.G. “It has submitted interim efficacy data to the DCGI and the SEC will soon meet to decide whether to recommend a full emergency use authorization to Covaxin,” the person quoted above said. Experts have said that they are already seeing an increase in registrations for vaccinations at hospitals such as Delhi’s All India Institute of Medical Sciences where Covaxin is being administered after Bharat Biotech last week announced its interim phase 3 trial data that showed the vaccine has an efficacy of 80.6%. The low uptake of Covaxin is primarily on account of some states such as Chhattisgarh being hesitant to use Bharat Biotech’s jabs because of lack of efficacy data earlier.

History of this topic

The right way to counter a poor Covaxin safety study
4 months, 3 weeks ago
BHU’s Covaxin safety study riddled with major limitations
6 months, 4 weeks ago
1 in 3 Covaxin takers reported adverse events, BHU study claims
7 months, 1 week ago
BHU study: Over 30 per cent of Covaxin recipients report adverse events
7 months, 1 week ago
‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago
Covishield more effective than Covaxin: Study
9 months, 2 weeks ago
What study on Covishield versus Covaxin vaccine reveals
9 months, 2 weeks ago
Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
1 year, 8 months ago
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago
Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
1 year, 11 months ago
Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago
Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
1 year, 11 months ago
Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago
Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster
1 year, 11 months ago
Nasal vaccines to roll out in private hospitals soon
2 years ago
90L in city yet to get booster shot, but BMC has only 6K Covaxin doses
2 years ago
Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey
2 years ago
Bharat Biotech’s nasal vaccine to be available as booster dose
2 years ago
Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years ago
SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago
Bharat Biotech misstated Covaxin trial data
2 years ago
India records 937 Covid infections in 24 hours, active cases decline by 324. Check state-wise data
2 years, 1 month ago
50 million doses of Covaxin set to expire early 2023 due to poor offtake
2 years, 1 month ago
COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take
2 years, 1 month ago
COVID-19: Corbevax to be given as boosters at vaccination centres from today
2 years, 4 months ago
Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago
Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago
Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago
In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago
Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago
Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago
India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago
DC Edit | A good move, as Covid cases up
2 years, 5 months ago
NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 5 months ago
Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 5 months ago
Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 5 months ago
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech
2 years, 6 months ago
Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech
2 years, 6 months ago
NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap
2 years, 6 months ago
Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago
Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago
Germany recognises Bharat Biotech's Covaxin for travel from June 1
2 years, 6 months ago
BMC reduces gap between 2nd-3rd Covid vaccine doses for international travellers. Details
2 years, 7 months ago
Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago
Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago
Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today
2 years, 7 months ago
No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court
2 years, 7 months ago

Discover Related